Ameriprise Financial »

Aeglea Biotherapeutics shares owned by Ameriprise Financial

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Ameriprise Financial from 13F filings

Historical chart of Ameriprise Financial investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Ameriprise Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Ameriprise Financial

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.3M 38k 32.76

More positions owned by Ameriprise Financial

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Broadcom (AVGO)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
iShares S&P 500 Index (IVV)
Facebook Inc cl a (META)
Visa (V)
Lam Research (LRCX)
Alphabet Inc Class C cs (GOOG)
Bank of America Corporation (BAC)
Wal-Mart Stores (WMT)
Vanguard S&p 500 Etf idx (VOO)

View all positions for Ameriprise Financial

Top funds holding Aeglea Biotherapeutics

FMR
BlackRock
Rtw Investments
Vanguard Group
Fairmount Funds Management
VR Adviser
Capital Research and Management Company - Division 3
Perceptive Advisors
Driehaus Capital Management
Commodore Capital
State Street Corporation
TCG Crossover Management
Tang Capital Management
Geode Capital Management
Braidwell

View all funds holding Aeglea Biotherapeutics